Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea

Key facts

Where
Beijing, ChinaSee the site

Where in China

  • Beijing Chaoyang Hospital affiliated to Capital Medical UniversityBeijing, ChinaContact: Zhiling ZhaoTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Capital Medical University
Trial code
NCT07277608
Record updated
11 December 2025
Original description
To clarify the clinical features of patients with obstructive sleep apnea; To construct a multi-omics database of patients with obstructive sleep apnea, and compare the effects of different degrees of sleep apnea on prognosis, immunity, and metabolism. The medium and long-term prognosis, complications, comorbidities, risk factors, and immune and metabolic dynamics of patients with sleep apnea after treatment were studied. To elucidate the biomarkers and therapeutic targets associated with obstructive sleep apnea.Read full original descriptionShow less

To clarify the clinical features of patients with obstructive sleep apnea; To construct a multi-omics database of patients with obstructive sleep apnea, and compare the effects of different degrees of sleep apnea on prognosis, immunity, and metabolism. The medium and long-term prognosis, complications, comorbidities, risk factors, and immune and metabolic dynamics of patients with sleep apnea after treatment were studied. To elucidate the biomarkers and therapeutic targets associated with obstructive sleep apnea.

Inclusion: Patients with suspected obstructive sleep apnea (OSA) admitted to the sleep center of the respiratory Department of Beijing Chaoyang Hospital, Capital Medical University; Volunteer to participate in the study and sign an informed consent, and can complete at least 1 year of follow-up.

Exclusion: Patients with obstructive sleep apnea who have been treated with impermanent positive pressure ventilation; Patients with severe respiratory failure requiring mechanical ventilation; Patients with severe heart, lung, liver, kidney, and central nervous system damage; Pregnant or lactating women; Refuse to participate in follow-up visits and/or take biological samples.

ClinicalTrials.gov NCT07277608